Wilms Tumor — Trials · CancerIndex

Clinical trials

Registered studies

106 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 31
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: 24.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04814758	DWI in the Diagnosis of Histological Types of Nephroblastoma in Children	unknown	N/A	230	Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER	1	Mar 24, 2021	clinicaltrials
NCT04758455	The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and Recurrence	unknown	N/A	75	Mansoura UniversityOTHER	1	Feb 17, 2021	clinicaltrials